The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Demerol (Meperidine)-Global Market Insights and Sales Trends 2024
Synopsis
Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
The global Demerol (Meperidine) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Demerol (Meperidine) in various end use industries. The expanding demands from the Anesthesia, Cough Treatment and Diarrhea Treatment,, are propelling Demerol (Meperidine) market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid segment is estimated at % CAGR for the next seven-year period.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Demerol (Meperidine), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Demerol (Meperidine) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Demerol (Meperidine) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Demerol (Meperidine) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Demerol (Meperidine) covered in this report include Purdue Pharma, Egalet, Boehringer Ingelheim, Janssen, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals and Actavis, etc.
The global Demerol (Meperidine) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer
Global Demerol (Meperidine) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Demerol (Meperidine) market, Segment by Type:
Powder
Liquid
Global Demerol (Meperidine) market, by Application
Anesthesia
Cough Treatment
Diarrhea Treatment
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Demerol (Meperidine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Demerol (Meperidine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
The global Demerol (Meperidine) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Demerol (Meperidine) in various end use industries. The expanding demands from the Anesthesia, Cough Treatment and Diarrhea Treatment,, are propelling Demerol (Meperidine) market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liquid segment is estimated at % CAGR for the next seven-year period.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Demerol (Meperidine), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Demerol (Meperidine) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Demerol (Meperidine) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Demerol (Meperidine) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Demerol (Meperidine) covered in this report include Purdue Pharma, Egalet, Boehringer Ingelheim, Janssen, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals and Actavis, etc.
The global Demerol (Meperidine) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer
Global Demerol (Meperidine) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Demerol (Meperidine) market, Segment by Type:
Powder
Liquid
Global Demerol (Meperidine) market, by Application
Anesthesia
Cough Treatment
Diarrhea Treatment
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Demerol (Meperidine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Demerol (Meperidine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Demerol (Meperidine) Market Overview
1.1 Demerol (Meperidine) Product Overview
1.2 Demerol (Meperidine) Market Segment by Type
1.2.1 Powder
1.2.2 Liquid
1.3 Global Demerol (Meperidine) Market Size by Type
1.3.1 Global Demerol (Meperidine) Market Size Overview by Type (2018-2029)
1.3.2 Global Demerol (Meperidine) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Demerol (Meperidine) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Demerol (Meperidine) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Demerol (Meperidine) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Demerol (Meperidine) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Demerol (Meperidine) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Demerol (Meperidine) Sales Breakdown by Type (2018-2023)
2 Global Demerol (Meperidine) Market Competition by Company
2.1 Global Top Players by Demerol (Meperidine) Sales (2018-2023)
2.2 Global Top Players by Demerol (Meperidine) Revenue (2018-2023)
2.3 Global Top Players by Demerol (Meperidine) Price (2018-2023)
2.4 Global Top Manufacturers Demerol (Meperidine) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Demerol (Meperidine) Market Competitive Situation and Trends
2.5.1 Demerol (Meperidine) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Demerol (Meperidine) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Demerol (Meperidine) as of 2022)
2.7 Date of Key Manufacturers Enter into Demerol (Meperidine) Market
2.8 Key Manufacturers Demerol (Meperidine) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Demerol (Meperidine) Status and Outlook by Region
3.1 Global Demerol (Meperidine) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Demerol (Meperidine) Historic Market Size by Region
3.2.1 Global Demerol (Meperidine) Sales in Volume by Region (2018-2023)
3.2.2 Global Demerol (Meperidine) Sales in Value by Region (2018-2023)
3.2.3 Global Demerol (Meperidine) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Demerol (Meperidine) Forecasted Market Size by Region
3.3.1 Global Demerol (Meperidine) Sales in Volume by Region (2024-2029)
3.3.2 Global Demerol (Meperidine) Sales in Value by Region (2024-2029)
3.3.3 Global Demerol (Meperidine) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Demerol (Meperidine) by Application
4.1 Demerol (Meperidine) Market Segment by Application
4.1.1 Anesthesia
4.1.2 Cough Treatment
4.1.3 Diarrhea Treatment
4.2 Global Demerol (Meperidine) Market Size by Application
4.2.1 Global Demerol (Meperidine) Market Size Overview by Application (2018-2029)
4.2.2 Global Demerol (Meperidine) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Demerol (Meperidine) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Demerol (Meperidine) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Demerol (Meperidine) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Demerol (Meperidine) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Demerol (Meperidine) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Demerol (Meperidine) Sales Breakdown by Application (2018-2023)
5 North America Demerol (Meperidine) by Country
5.1 North America Demerol (Meperidine) Historic Market Size by Country
5.1.1 North America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Demerol (Meperidine) Sales in Volume by Country (2018-2023)
5.1.3 North America Demerol (Meperidine) Sales in Value by Country (2018-2023)
5.2 North America Demerol (Meperidine) Forecasted Market Size by Country
5.2.1 North America Demerol (Meperidine) Sales in Volume by Country (2024-2029)
5.2.2 North America Demerol (Meperidine) Sales in Value by Country (2024-2029)
6 Europe Demerol (Meperidine) by Country
6.1 Europe Demerol (Meperidine) Historic Market Size by Country
6.1.1 Europe Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Demerol (Meperidine) Sales in Volume by Country (2018-2023)
6.1.3 Europe Demerol (Meperidine) Sales in Value by Country (2018-2023)
6.2 Europe Demerol (Meperidine) Forecasted Market Size by Country
6.2.1 Europe Demerol (Meperidine) Sales in Volume by Country (2024-2029)
6.2.2 Europe Demerol (Meperidine) Sales in Value by Country (2024-2029)
7 Asia-Pacific Demerol (Meperidine) by Region
7.1 Asia-Pacific Demerol (Meperidine) Historic Market Size by Region
7.1.1 Asia-Pacific Demerol (Meperidine) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Demerol (Meperidine) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Demerol (Meperidine) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Demerol (Meperidine) Forecasted Market Size by Region
7.2.1 Asia-Pacific Demerol (Meperidine) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Demerol (Meperidine) Sales in Value by Region (2024-2029)
8 Latin America Demerol (Meperidine) by Country
8.1 Latin America Demerol (Meperidine) Historic Market Size by Country
8.1.1 Latin America Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Demerol (Meperidine) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Demerol (Meperidine) Sales in Value by Country (2018-2023)
8.2 Latin America Demerol (Meperidine) Forecasted Market Size by Country
8.2.1 Latin America Demerol (Meperidine) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Demerol (Meperidine) Sales in Value by Country (2024-2029)
9 Middle East and Africa Demerol (Meperidine) by Country
9.1 Middle East and Africa Demerol (Meperidine) Historic Market Size by Country
9.1.1 Middle East and Africa Demerol (Meperidine) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Demerol (Meperidine) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Demerol (Meperidine) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Demerol (Meperidine) Forecasted Market Size by Country
9.2.1 Middle East and Africa Demerol (Meperidine) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Demerol (Meperidine) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Purdue Pharma
10.1.1 Purdue Pharma Company Information
10.1.2 Purdue Pharma Introduction and Business Overview
10.1.3 Purdue Pharma Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Purdue Pharma Demerol (Meperidine) Products Offered
10.1.5 Purdue Pharma Recent Development
10.2 Egalet
10.2.1 Egalet Company Information
10.2.2 Egalet Introduction and Business Overview
10.2.3 Egalet Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Egalet Demerol (Meperidine) Products Offered
10.2.5 Egalet Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Demerol (Meperidine) Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Janssen
10.4.1 Janssen Company Information
10.4.2 Janssen Introduction and Business Overview
10.4.3 Janssen Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Janssen Demerol (Meperidine) Products Offered
10.4.5 Janssen Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sanofi Demerol (Meperidine) Products Offered
10.5.5 Sanofi Recent Development
10.6 Sun Pharmaceuticals
10.6.1 Sun Pharmaceuticals Company Information
10.6.2 Sun Pharmaceuticals Introduction and Business Overview
10.6.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceuticals Demerol (Meperidine) Products Offered
10.6.5 Sun Pharmaceuticals Recent Development
10.7 Mallinckrodt Pharmaceuticals
10.7.1 Mallinckrodt Pharmaceuticals Company Information
10.7.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
10.7.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Products Offered
10.7.5 Mallinckrodt Pharmaceuticals Recent Development
10.8 Endo Pharmaceuticals
10.8.1 Endo Pharmaceuticals Company Information
10.8.2 Endo Pharmaceuticals Introduction and Business Overview
10.8.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Endo Pharmaceuticals Demerol (Meperidine) Products Offered
10.8.5 Endo Pharmaceuticals Recent Development
10.9 Actavis
10.9.1 Actavis Company Information
10.9.2 Actavis Introduction and Business Overview
10.9.3 Actavis Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Actavis Demerol (Meperidine) Products Offered
10.9.5 Actavis Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Information
10.10.2 Pfizer Introduction and Business Overview
10.10.3 Pfizer Demerol (Meperidine) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Pfizer Demerol (Meperidine) Products Offered
10.10.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Demerol (Meperidine) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Demerol (Meperidine) Industrial Chain Analysis
11.4 Demerol (Meperidine) Market Dynamics
11.4.1 Demerol (Meperidine) Industry Trends
11.4.2 Demerol (Meperidine) Market Drivers
11.4.3 Demerol (Meperidine) Market Challenges
11.4.4 Demerol (Meperidine) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Demerol (Meperidine) Distributors
12.3 Demerol (Meperidine) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
